Back to Search Start Over

Eplerenone for chronic central serous chorioretinopathy in patients with active, previously untreated disease for more than 4 months (VICI): a randomised, double-blind, placebo-controlled trial

Authors :
Lotery, Andrew
Sivaprasad, Sobha
O'Connell, Abby
Harris, Rosie A
Culliford, Lucy
Ellis, Lucy
Cree, Angela
Madhusudhan, Savita
Behar-Cohen, Francine
Chakravarthy, Usha
Peto, Tunde
Rogers, Chris A
Reeves, Barnaby C
Investigators, VICI Trial
Source :
LANCET
Publication Year :
2020

Details

Language :
English
Database :
OpenAIRE
Journal :
LANCET
Accession number :
edsair.core.ac.uk....f55365ce308752e21ffad43a380a55f8

Tools

Authors Abstract Subjects Details